Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion, NRT and CBT on Smoking Cessation and Relapse in Schizophrenia
NCT00320697Phase 4Completed
- Sponsor
- North Suffolk Community Services
- Start
- Apr 2006
- Primary completion
- Oct 2008
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupropion and nicotine patch in nicotine dependence (3 arms), sponsored by North Suffolk Community Services. Primary endpoint: 7-day point-prevalence abstinence at 44 weeks. Started Apr 2006; status: completed.
02
Drugs
bupropionnicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00320697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320697.